Viatris' Mylan Unit Cleared of Antitrust Probe by Department of Justice

Tuesday, 2 July 2024, 12:07
The Department of Justice concluded its investigation into Viatris' Mylan unit for alleged drug price-fixing with a clearance, leading to a 2% increase in shares. The resolution of the probe marks a milestone for the company and signals a positive outcome in the antitrust realm. Investors reacted positively to the news, indicating a potential boost in confidence in Viatris' operations.
Seeking Alpha
Viatris' Mylan Unit Cleared of Antitrust Probe by Department of Justice

Viatris Mylan Cleared of DOJ Drug Price-Fixing Probe

The Department of Justice has cleared Viatris' Mylan unit of antitrust investigation, resulting in a 2% increase in shares. This resolution is a significant development for the company and could enhance investor confidence in its operations.

Do you want to advertise here? Contact us

Related posts

Do you want to advertise here? Contact us
Do you want to advertise here? Contact us
Newsletter

We carefully select news from the world of finance and publish it for our users. We understand the importance of reliable and up-to-date information for people in the financial world. Do you want to receive news in a convenient format and always have it at hand — subscribe to our newsletter and make your analytical work more effective.

Subscribe